v3.26.1
Fair Value of Financial Instruments (Tables)
9 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Summary of Unobservable Inputs and Ranges

Our Level 3 valuation techniques, unobservable inputs and ranges were categorized as follows for ASC 820 purposes ($ in thousands):

 

Asset Category

 

Fair value at June 30, 2026

 

 

Valuation Technique

 

Unobservable Input

 

Range of Input
(Weighted Average)
(1)

First lien

 

$

88,413

 

 

Market Comparable

 

Broker/Dealer bids or quotes

 

N/A

First lien

 

 

2,102,418

 

 

Market Comparable

 

Market yield

 

7.8% - 21.6% (10.0%)

First lien

 

 

34,059

 

 

Enterprise Market Value

 

EBITDA multiple

 

6.0x - 17.8x (9.4x)

First lien

 

 

5,806

 

 

Market Comparable

 

Revenue multiple

 

0.7x - 0.9x (0.9x)

Subordinated debt

 

 

13,575

 

 

Market Comparable

 

Market yield

 

11.2% - 16.4% (13.9%)

Subordinated debt

 

 

2,114

 

 

Enterprise Market Value

 

Revenue multiple

 

0.6x - 0.9x (0.6x)

Subordinated debt

 

 

3,995

 

 

Enterprise Market Value

 

EBITDA multiple

 

7.5x - 30.3x (27.2x)

Equity

 

 

173,300

 

 

Enterprise Market Value

 

EBITDA multiple

 

4.5x - 17.8x (10.5x)

Equity

 

 

529

 

 

Enterprise Market Value

 

Revenue multiple

 

0.5x - 1.3x (0.3x)

Total Level 3 investments

 

$

2,424,209

 

 

 

 

 

 

 

Long-Term Credit Facility

 

$

318,310

 

 

Market Comparable

 

Market yield

 

5.4%

____________________________________________

(1)
The weighted averages disclosed in the table above were weighted by their relative fair value.

 

Asset Category

 

Fair value at September 30, 2025

 

 

Valuation Technique

 

Unobservable Input

 

Range of Input
(Weighted Average)
(1)

First lien

 

$

114,625

 

 

Market Comparable

 

Broker/Dealer bids
or quotes

 

N/A

First lien

 

 

2,377,201

 

 

Market Comparable

 

Market Yield

 

4.0% - 24.5% (9.9%)

First lien

 

 

17,969

 

 

Enterprise Market Value

 

EBITDA multiple

 

8.3x

First lien

 

 

3,836

 

 

Market Comparable

 

Revenue Multiple

 

0.6x

Second Lien

 

 

995

 

 

Market Comparable

 

Broker/Dealer bids
or quotes

 

N/A

Subordinated debt

 

 

17,439

 

 

Market Comparable

 

Market Yield

 

7.0% - 25.4% (17.1%)

Subordinated debt

 

 

547

 

 

Enterprise Market Value

 

EBITDA multiple

 

14.8x

Equity

 

 

196,398

 

 

Enterprise Market Value

 

EBITDA multiple

 

0.6x - 28.3x (10.8x)

Total Level 3 investments

 

$

2,729,010

 

 

 

 

 

 

 

Long-Term Credit Facility

 

$

683,837

 

 

Market Comparable

 

Market Yield

 

4.8%

 

(1)
The weighted averages disclosed in the table above were weighted by their relative fair value.
Summary of Investments, Cash and Cash Equivalents, Credit Facility, or Prior Credit Facility, Notes and Asset Backed Debt

Our investments, cash and cash equivalents, Credit Facility, 2029 Notes, 2031 Notes, 2038-R Asset-Backed Debt, 2036 Asset-Backed Debt, 2036-R Asset-Backed Debt, and 2037 Asset-Backed Debt were categorized as follows in the fair value hierarchy for ASC 820 purposes ($ in thousands):

 

 

 

Fair Value at June 30, 2026

 

Description

 

Fair Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Measured at Net
Asset Value
(1)

 

First lien

 

$

2,230,696

 

 

$

 

 

$

 

 

$

2,230,696

 

 

$

 

Subordinate debt

 

 

19,684

 

 

 

 

 

 

 

 

 

19,684

 

 

 

 

Equity

 

 

254,278

 

 

 

 

 

 

 

 

 

173,829

 

 

 

80,449

 

Total investments

 

 

2,504,658

 

 

 

 

 

 

 

 

 

2,424,209

 

 

 

80,449

 

Cash equivalents

 

 

50,725

 

 

 

50,725

 

 

 

 

 

 

 

 

 

 

Total investments and cash equivalents

 

$

2,555,383

 

 

$

50,725

 

 

$

 

 

$

2,424,209

 

 

$

80,449

 

Long Term Credit Facility payable

 

$

318,310

 

 

$

 

 

$

 

 

$

318,310

 

 

$

 

2029 Notes payable (2)

 

 

196,212

 

 

 

 

 

 

196,212

 

 

 

 

 

 

 

2031 Notes payable (3)

 

 

106,848

 

 

 

106,848

 

 

 

 

 

 

 

 

 

 

2036-R Asset-Backed Debt(2)

 

 

286,609

 

 

 

 

 

 

 

 

 

286,609

 

 

 

 

2037 Asset-Backed Debt (2)

 

 

387,266

 

 

 

 

 

 

 

 

 

387,266

 

 

 

 

2038-R Asset-Backed Debt(2)

 

 

284,865

 

 

 

 

 

 

 

 

 

284,865

 

 

 

 

Total debt

 

$

1,580,110

 

 

$

106,848

 

 

$

196,212

 

 

$

1,277,050

 

 

$

 

———————————————

(1)
In accordance with ASC Subtopic 820-10, Fair Value Measurements and Disclosures, or ASC 820-10, our equity investments in PSSL and PSSL II are measured using net asset value per share (or its equivalent) as a practical expedient for fair value, and thus have not been classified in the fair value hierarchy.
(2)
We elected not to apply the fair value option allowed by ASC 825-10 to the 2029 Notes, 2038-R Asset-Backed Debt, 2036-R Asset-Backed Debt, and 2037 Asset-Backed Debt and thus the balance reported in the Consolidated Statement of Assets and Liabilities represents the carrying value, which approximates the fair value.
(3)
We elected not to apply the fair value option allowed by ASC 825-10 to the 2031 Notes and the balance reported on the Consolidated Statement of Assets and Liabilities represents the carrying value. The 2031 Notes trade on the NYSE under the symbol PFLA and the fair value in this chart is based on the closing price on June 30, 2026.

 

 

 

 

Fair Value at September 30, 2025

 

Description

 

Fair Value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Measured at Net
Asset Value
(1)

 

First lien

 

$

2,513,631

 

 

$

 

 

$

 

 

$

2,513,631

 

 

$

 

Second lien and Subordinate debt

 

 

18,981

 

 

 

 

 

 

 

 

 

18,981

 

 

 

 

Equity

 

 

240,716

 

 

 

 

 

 

 

 

 

196,398

 

 

 

44,318

 

Total investments

 

 

2,773,328

 

 

 

 

 

 

 

 

 

2,729,010

 

 

 

44,318

 

Cash equivalents

 

 

40,729

 

 

 

40,729

 

 

 

 

 

 

 

 

 

 

Total investments and cash equivalents

 

$

2,814,057

 

 

$

40,729

 

 

$

 

 

$

2,729,010

 

 

$

44,318

 

Long Term Credit Facility payable

 

$

683,837

 

 

$

 

 

$

 

 

$

683,837

 

 

$

 

2026 Notes payable(2)

 

 

184,609

 

 

 

 

 

 

184,609

 

 

 

 

 

 

 

2036 Asset-Backed Debt(2)

 

 

284,627

 

 

 

 

 

 

 

 

 

284,627

 

 

 

 

2036-R Asset-Backed Debt(2)

 

 

265,366

 

 

 

 

 

 

 

 

 

265,366

 

 

 

 

2037 Asset-Backed Debt(2)

 

 

358,331

 

 

 

 

 

 

 

 

 

358,331

 

 

 

 

Total debt

 

$

1,776,770

 

 

$

 

 

$

184,609

 

 

$

1,592,161

 

 

$

 

 

(1)
In accordance with ASC Subtopic 820-10, Fair Value Measurements and Disclosures, or ASC 820-10, our equity investments in PSSL is measured using net asset value per share (or its equivalent) as a practical expedient for fair value in accordance with the specialized accounting guidance for investment companies, and thus has not been classified in the fair value hierarchy.
(2)
We elected not to apply the fair value option allowed by ASC 825-10 to the 2026 Notes, 2036 Asset-Backed Debt, the 2036-R Asset-Backed Debt, and the 2037 Asset-Backed Debt and thus the balance reported in the Consolidated Statement of Assets and Liabilities represents the carrying value, which approximates the fair value.
Reconciliation of Investments Measured at Fair Value Using Significant Unobservable Inputs Level 3

The tables below show a reconciliation of the beginning and ending balances for fair valued investments measured using significant unobservable inputs (Level 3)

($ in thousands):

 

 

 

Nine Months Ended June 30, 2026

 

Description

 

First Lien

 

 

Second lien,
subordinated
debt and equity
investments

 

 

Totals

 

Beginning balance

 

$

2,513,631

 

 

$

215,379

 

 

$

2,729,010

 

Net realized gain (loss)

 

 

(8,377

)

 

 

39,692

 

 

 

31,315

 

Net change in unrealized appreciation (depreciation)

 

 

(27,499

)

 

 

(17,855

)

 

 

(45,354

)

Purchases, PIK interest, net discount accretion and non-cash exchanges

 

 

603,445

 

 

 

13,886

 

 

 

617,331

 

Sales, repayments and non-cash exchanges

 

 

(850,504

)

 

 

(57,589

)

 

 

(908,093

)

Transfers in and/or out of Level 3

 

 

 

 

 

 

 

 

 

Ending balance

 

$

2,230,696

 

 

$

193,513

 

 

$

2,424,209

 

Net change in unrealized appreciation (depreciation) reported within the net change in unrealized
appreciation (depreciation) on investments in our consolidated statements of operations
attributable to our Level 3 assets still held at the reporting date.

 

$

(31,919

)

 

$

(13,514

)

 

$

(45,433

)

 

 

 

Nine Months Ended June 30, 2025

 

Description

 

First Lien

 

 

Second lien,
subordinated
debt and equity
investments

 

 

Totals

 

Beginning balance

 

$

1,746,697

 

 

$

171,142

 

 

$

1,917,839

 

Net realized gain (loss)

 

 

(12,997

)

 

 

21,352

 

 

 

8,355

 

Net change in unrealized appreciation (depreciation)

 

 

(4,757

)

 

 

(9,246

)

 

 

(14,003

)

Purchases, PIK interest, net discount accretion and non-cash exchanges

 

 

1,077,943

 

 

 

21,151

 

 

 

1,099,094

 

Sales, repayments and non-cash exchanges

 

 

(656,285

)

 

 

(13,171

)

 

 

(669,456

)

Transfers in and/or out of Level 3

 

 

 

 

 

 

 

 

 

Ending balance

 

$

2,150,601

 

 

$

191,228

 

 

$

2,341,829

 

Net change in unrealized depreciation reported within the net change in unrealized
depreciation on investments in our consolidated statements of operations
attributable to our Level 3 assets still held at the reporting date.

 

$

(3,778

)

 

$

10,025

 

 

$

6,247

 

Reconciliation of Liabilities Measured at Fair Value Using Significant Unobservable Inputs Level 3

The table below shows a reconciliation of the beginning and ending balances for liabilities recognized at fair value and measured using significant unobservable inputs (Level 3)($ in thousands):

 

 

 

 

Nine Months Ended June 30,

 

Long-Term Credit Facility

 

2026

 

 

2025

 

Beginning balance (cost – $683,855 and $443,855, respectively)

 

$

683,837

 

 

$

443,880

 

Net change in unrealized (depreciation) appreciation included in earnings

 

 

(27

)

 

 

(15

)

Borrowings

 

 

341,500

 

 

 

260,000

 

Repayments

 

 

(707,000

)

 

 

(405,000

)

Ending balance (cost – $318,355 and $298,855, respectively)

 

$

318,310

 

 

$

298,865

 

Schedule of Non US Dollar Outstanding Borrowings on Credit Facility

As of June 30, 2026, we had outstanding non-U.S. dollar borrowings on our Credit Facility. The following table shows our non-U.S. dollar borrowings as of June 30, 2026 (CAD and $ in thousands):

 

Foreign Currency

 

Amount
Borrowed

 

 

Borrowing Cost

 

 

Current Value

 

 

Reset Date

 

Unrealized appreciation (depreciation)

 

Canadian Dollar

 

 

CAD 2,000

 

 

$

1,455

 

 

$

1,410

 

 

7/1/26

 

 

(45

)

 

As of September 30, 2025 we had outstanding non-U.S. dollar borrowings on our Credit Facility. The following table shows our non-U.S dollar borrowings as of September 30, 2025. (CAD and $ in thousands):

 

Foreign Currency

 

Amount
Borrowed

 

 

Borrowing Cost

 

 

Current Value

 

 

Reset Date

 

Unrealized appreciation (depreciation)

 

Canadian Dollar

 

 

CAD 2,000

 

 

$

1,455

 

 

$

1,437

 

 

10/1/2025

 

 

(18

)